Chicago Atlantic BDC, Inc. (LIEN) Company Overview

US | Financial Services | Asset Management | NASDAQ

What does Chicago Atlantic BDC do?

Chicago Atlantic BDC, Inc. is a Nasdaq-listed specialty finance company that lends to privately held middle-market businesses, with a primary emphasis on cannabis operators and selected niche or underfollowed industries. It operates as a business development company, or BDC, under the Investment Company Act of 1940 and has elected regulated investment company tax treatment. In plain English, LIEN raises equity and debt capital, deploys that capital into mostly secured loans, collects interest and fees, pays operating and financing costs, and distributes much of its taxable income to stockholders.

$364.0M
Investments at fair value, March 31, 2026
$304.2M
Net assets, March 31, 2026
$13.33
Net asset value per share, March 31, 2026
22.82M
Common shares outstanding, March 31, 2026

Why is the cannabis focus strategically important?

State-licensed cannabis companies have often faced limited access to ordinary bank credit because federal law and banking rules create legal and compliance friction. That financing gap can support high contractual yields and lender protections for specialist capital providers. LIEN’s stated objective is to maximize risk-adjusted returns on equity through direct loans, a model described in its 2025 Form 10-K and its investor-relations site.

Why it matters
LIEN is not a diversified commercial bank. Its value depends on underwriting specialized borrowers, protecting principal through collateral and covenants, and earning enough spread to compensate for concentration, legal and liquidity risks.

How does Chicago Atlantic BDC make money?

The economic engine has three layers. First, the company earns cash interest from loans, often at floating rates tied to a benchmark plus a spread and sometimes subject to a minimum floor. Second, it earns origination, structuring, amendment, prepayment and other fee income. Third, the portfolio may generate realized or unrealized gains and losses when investments are repaid, restructured or revalued. These gains and losses can move reported net assets even when cash interest remains stable.

1. Source
Adviser identifies cannabis and niche-credit borrowers that lack abundant conventional financing.
2. Underwrite
LIEN assesses collateral, cash flow, licenses, ownership, covenants and downside recovery.
3. Structure
Loans generally include contractual interest, fees, maturity dates and lender protections.
4. Distribute
Net investment income supports quarterly distributions, subject to board approval and RIC rules.

Which revenue stream mattered most in the latest quarter?

Q1 2026 investment-income mix
Interest income — $14.58M, about 87.3% of total investment income
Fee income — $2.12M, about 12.7% of total investment income
Calculated from Q1 2026 reported interest and fee income. Interest remains the core recurring engine, while fees can make quarterly results lumpier.

For the three months ended March 31, 2026, total investment income was $16.70 million, including $14.58 million of combined interest income and $2.12 million of combined fee income. Because fee revenue can depend on originations, amendments and repayments, students should avoid annualizing a single quarter’s fee contribution without reviewing the underlying transactions.

What did the first quarter of 2026 show?

The latest official quarter showed portfolio growth, higher investment income and a modest increase in net asset value, but also materially greater use of the revolving credit facility. The company’s first-quarter 2026 earnings release and March 31, 2026 Form 10-Q provide the freshest reported evidence.

Metric Q1 2026 / March 31, 2026 Prior-quarter / Dec. 31, 2025 Interpretation
Total investment income $16.70M $14.23M Higher interest and fee income expanded the top line.
Net investment income $9.96M $8.27M Core earnings improved despite higher interest expense.
Net investment income per share $0.44 $0.36 Per-share earning power rose quarter over quarter.
Net increase from operations $8.54M $8.25M Unrealized depreciation absorbed part of investment income.
NAV per share $13.33 $13.30 Book value was broadly stable and slightly higher.

Why did net income lag net investment income?

LIEN recorded a $1.43 million net unrealized loss in Q1 2026. Net investment income of $9.96 million therefore translated into an $8.54 million increase in net assets from operations. This distinction is central to BDC analysis: net investment income measures the recurring economics of interest and fees after expenses, while changes in investment fair value reveal credit migration, market assumptions and expected recoveries.

59.6%Q1 2026 net investment income margin, calculated as $9.96M divided by $16.70M of total investment income.

How are the portfolio, leverage and liquidity changing?

At March 31, 2026, investments at fair value totaled $363.97 million, up from $333.31 million at December 31, 2025. That 9.2% sequential increase indicates active deployment. Total assets rose to $373.13 million from $342.00 million, while the revolving line of credit increased to $54.50 million from $25.00 million. Cash remained modest at $3.35 million, so liquidity analysis must include available borrowing capacity, expected repayments and the quality of portfolio cash flows rather than cash alone.

Balance-sheet growth from year-end 2025 to March 31, 2026
Investments at fair value$364.0M
Net assets$304.2M
Total liabilities$68.9M
Revolver borrowings$54.5M
Bars are scaled to total assets of $373.1M at March 31, 2026. The portfolio is predominantly financed with equity, but debt use rose sharply during Q1.

What does leverage add—and what can it take away?

Borrowing can increase returns on equity when loan yields exceed financing costs. The same leverage also magnifies credit losses and exposes earnings to higher interest expense. Q1 2026 interest expense was $1.02 million, more than double the $0.46 million reported for the quarter ended December 31, 2025. For LIEN, the relevant question is not whether debt is inherently good or bad, but whether incremental assets maintain underwriting quality and produce a durable spread after funding costs, management fees and incentive fees.

Balance-sheet item March 31, 2026 Dec. 31, 2025 Change
Investments at fair value $363.97M $333.31M +$30.65M
Cash and cash equivalents $3.35M $2.93M +$0.41M
Revolving line of credit $54.50M $25.00M +$29.50M
Total net assets $304.18M $303.41M +$0.78M

Which strategic turning points shaped LIEN?

LIEN’s present identity is the result of a sequence of governance, branding and portfolio decisions rather than a long operating history as an industrial company. The most useful history is therefore the history of its investment mandate, public-market structure and adviser relationship.

  1. 2021
    The predecessor vehicle was organized as a BDC, establishing the regulated closed-end investment-company framework that still governs leverage, reporting and distributions.
  2. 2022
    The company completed its public listing, giving investors access to a portfolio focused on direct loans to cannabis and other specialty borrowers.
  3. 2024
    The platform continued to deepen cannabis credit exposure while emphasizing senior-secured structures and negotiated lender protections.
  4. 2025
    The company adopted the Chicago Atlantic BDC identity and LIEN ticker, aligning the public vehicle more closely with the adviser’s broader private-credit brand.
  5. Q1 2026
    Portfolio fair value increased to $364.0M and revolver borrowings rose to $54.5M, marking a faster deployment phase.
  6. June 2026
    LIEN agreed to combine with Chicago Atlantic Real Estate Finance, subject to approvals and closing conditions, potentially creating a larger specialty-credit platform.

Why does the proposed REFI merger matter?

On June 17, 2026, LIEN and Chicago Atlantic Real Estate Finance entered into a merger agreement under which REFI is expected to elect BDC status and merge into LIEN, with LIEN surviving. The official merger agreement states that both boards, acting on special-committee recommendations, determined that existing holders would not be diluted by the transaction. Strategically, a larger asset base could improve diversification, market liquidity and operating scale. It also raises integration, approval, portfolio-overlap and governance questions that make the transaction the most important near-term event in the company’s history.

What gives Chicago Atlantic BDC a competitive advantage?

The company’s most credible advantage is specialization rather than sheer size. Cannabis lending requires regulatory knowledge, license analysis, collateral judgment and an ability to structure around cash-management and banking constraints. A generalist lender may view those burdens as disqualifying; a specialist may convert them into pricing power and tighter documentation. The adviser also operates across private credit and real-estate finance, which can expand sourcing and sector knowledge.

Sector underwriting knowledgeStrong
Portfolio diversificationLimited
Public capital accessModerate
Borrower switching frictionStrong

Which competitors pressure the model?

LIEN competes with private credit funds, specialty finance companies, cannabis-focused lenders, mortgage REITs, opportunistic credit vehicles and, where legally and operationally feasible, banks and credit unions. Competition is not limited to quoted interest rates. Borrowers also compare certainty of execution, speed, covenant flexibility, collateral requirements and willingness to fund follow-on needs. A competitor willing to accept weaker documentation can win business in the short run, while a lender with a cheaper cost of capital can compress spreads over time.

Competitive factor LIEN position Pressure point
Cannabis expertise Specialist adviser and repeat sector exposure Expertise must translate into lower losses, not only higher yields.
Loan structuring Ability to negotiate covenants, collateral and fees Borrowers may refinance when conventional credit expands.
Capital availability Public equity plus revolving-credit capacity Small scale can limit participation in very large transactions.
Portfolio monitoring Focused coverage can support active intervention Concentration makes a few adverse credits disproportionately important.

Who owns LIEN stock, and why does governance matter?

LIEN has one class of common stock with one vote per share, but economic influence is not completely dispersed. The 2025 proxy reported that Scott Gordon beneficially owned 3,850,800 shares, or 16.9%, and John Mazarakis beneficially owned 3,815,776 shares, or 16.7%, largely through interests associated with the adviser. The adviser itself was reported as the direct holder of 3,815,776 shares. Because several listed entities and individuals trace to the same block, those percentages should not be added together as independent ownership.

Holder or group Shares Ownership Why it matters
Scott Gordon 3,850,800 16.9% Executive-chair influence and economic alignment, including indirect adviser-held shares.
John Mazarakis 3,815,776 16.7% Significant influence through the adviser-related ownership block.
Directors and officers as a group 3,854,868 16.9% Shows meaningful insider exposure, though much overlaps adviser ownership.
Public and other holders Balance Majority Outside holders still determine outcomes when related parties abstain or approvals require broader support.

How does external management shape incentives?

The company has no employees and relies on Chicago Atlantic BDC Advisers for day-to-day investment and administrative operations. It pays management and incentive fees, while certain officer costs are allocated through reimbursement arrangements. In Q1 2026, the management fee was $1.53 million and the income-based incentive fee was $2.46 million. External management can provide a ready-made origination platform, but it also creates potential conflicts around asset growth, expense allocation, affiliated transactions and fee incentives. The board’s independent directors and committees therefore have an unusually important monitoring role. The 2025 proxy statement reported an eight-member classified board and described the independent committees overseeing audit, compensation and nominations.

Which KPIs best explain LIEN’s performance?

Traditional revenue growth is insufficient for a lender. Researchers need a compact dashboard linking portfolio quality, recurring earnings, leverage and distributions. The most useful metrics are net investment income per share, NAV per share, non-accrual exposure, portfolio yield, debt-to-equity, fee-income dependence and distribution coverage. Not every metric is disclosed in the earnings-release excerpt, so the 10-Q schedule of investments and notes remain essential.

NII per share
$0.44 in Q1 2026. Compare with the regular distribution to test recurring coverage.
NAV per share
$13.33 at March 31, 2026. Persistent declines can signal credit losses or distributions above economic earnings.
Portfolio fair value
$364.0M at March 31, 2026. Growth is useful only when underwriting quality and spreads remain intact.
Revolver balance
$54.5M at March 31, 2026, up $29.5M from year-end. Track funding cost and covenant headroom.
Unrealized change
-$1.43M in Q1 2026. Determine whether marks are idiosyncratic, temporary or early credit-warning signals.
Fee mix
About 12.7% of Q1 2026 investment income. High fee contribution can make quarterly results less repeatable.

How should distribution coverage be interpreted?

For a RIC, distributions are central to the investor proposition, but a high yield is not automatically evidence of strength. The cleanest first test is net investment income per share divided by the regular distribution per share. A second test examines NAV stability after distributions. If distributions are repeatedly funded by realized gains, fee spikes or return of capital rather than sustainable interest income, the payout may be less durable. Conversely, stable NAV and recurring NII coverage suggest that the portfolio’s contractual cash flows are supporting stockholder returns.

For LIEN, the core analytical chain is simple: underwriting quality drives cash interest, cash interest drives net investment income, and net investment income must support distributions without eroding NAV.

What risks could weaken Chicago Atlantic BDC’s outlook?

The most important risks are interconnected. Cannabis borrowers face federal illegality, shifting state regulation, taxation under Section 280E, limited banking access, price compression and operational volatility. Those pressures can reduce borrower cash flow at the same time that collateral values become harder to realize. Because LIEN is concentrated in a specialized industry, a sector-wide shock can affect several portfolio companies simultaneously.

Risk Financial transmission What to monitor
Credit deterioration Lower interest collection, non-accruals, restructuring and fair-value losses Watch-list loans, amendments, payment-in-kind income and unrealized marks.
Cannabis regulation Changes borrower tax burden, market access, licensing and refinancing options Federal scheduling, banking reform and state license economics.
Interest rates Floating-rate assets may earn less when benchmarks fall; debt costs may adjust differently Asset floors, liability repricing and net interest spread.
Concentration A small number of loans can drive NAV and earnings volatility Largest obligors, industry mix and collateral overlap.
External management Potential conflicts involving growth, fees and affiliated transactions Board approvals, waivers, expense allocation and related-party exposure.
Merger execution Approval delays, integration costs or unexpected portfolio issues Proxy materials, closing conditions, expense synergies and post-close leverage.

Which risk is easiest to underestimate?

Fair-value stability can create a false sense of security because private loans do not reprice every day like public bonds. Valuations depend on borrower performance, comparable yields, collateral and expected recovery. A modest quarterly unrealized decline may be temporary, but repeated marks, amendments or rising payment-in-kind interest can precede cash-credit problems. The risk section of the 2025 annual report should therefore be read alongside the schedule of investments, not as generic legal boilerplate.

Where could growth come from?

LIEN’s opportunity set has three main branches. The first is continued demand for specialist cannabis credit, especially where conventional lenders remain constrained. The second is expansion into other niche or underfollowed sectors where complexity supports stronger terms. The third is scale through the proposed REFI combination, which could broaden assets, improve public-market relevance and spread operating expenses across a larger portfolio.

Organic portfolio growth
$30.7M
Increase in investments at fair value from Dec. 31, 2025 to March 31, 2026.
Funding expansion
$29.5M
Increase in revolver borrowings over the same period, showing how growth was financed.

How could regulation change the opportunity?

Regulatory normalization is not a one-directional benefit. Easier banking access could improve borrower health, reduce taxes or increase refinancing options, lowering credit risk. Yet the same normalization could invite cheaper lenders and compress loan spreads. LIEN’s long-term success therefore depends on retaining advantages in underwriting, speed, structuring and relationships after the financing scarcity premium narrows.

Could diversification improve the risk profile?

Diversification into non-cannabis niches and a larger post-merger portfolio could reduce single-industry dependence. It could also dilute the specialist edge if the adviser moves too quickly into sectors where it lacks comparable experience. The best growth would add borrowers and industries whose risks are genuinely different, preserve seniority and collateral, and maintain net yields after credit costs and expenses.

Why does LIEN’s business model matter for valuation?

A BDC is commonly analyzed through net asset value, earnings power and distribution capacity rather than a conventional industrial-company DCF alone. The stock’s relationship to NAV reflects the market’s view of underwriting quality, fee structure, growth prospects and expected credit losses. A premium to NAV can support accretive equity issuance; a discount can make external growth harder and increase the importance of internally generated capital.

Valuation driver Why it matters Current anchor
NAV per share Baseline measure of portfolio value after liabilities $13.33 at March 31, 2026
Recurring NII per share Supports distributions and retained earnings $0.44 in Q1 2026
Credit-loss assumptions Small changes can materially alter NAV and future income $1.43M Q1 2026 net unrealized depreciation
Cost of leverage Determines whether borrowed funds increase or dilute returns $1.02M Q1 2026 interest expense
Fee burden Management and incentive fees reduce returns reaching common stockholders $3.99M combined Q1 2026 management and income-incentive fees
Merger outcome Could alter scale, diversification, expenses and liquidity Agreement signed June 17, 2026; approvals pending

What would a DCF-style model emphasize?

A forecast should model investment balances, average cash yield, fee income, funding cost, management and incentive fees, credit losses, share count and distributions. Terminal value is especially sensitive to assumptions about normalized credit costs and whether the portfolio can sustain returns without eroding NAV. Because loans mature and repay, reinvestment is not optional: the company must repeatedly originate new assets at acceptable spreads merely to preserve earnings.

What should students and investors monitor next?

The next phase will be defined by whether rapid deployment translates into durable per-share income and whether the proposed REFI transaction improves diversification without introducing new credit or governance problems. The company’s events and presentations page and official SEC-filings page are the most useful ongoing sources.

Merger approvals
Track stockholder votes, BDC election steps, closing conditions and the final exchange mechanics.
NAV trend
Compare each quarter with the $13.33 March 31, 2026 baseline.
NII coverage
Test whether recurring NII per share continues to cover regular distributions.
Non-accruals and amendments
Look for early signs that contractual yield is becoming less collectible.
Revolver use
Assess whether leverage growth remains proportionate to asset quality and equity capital.
Cannabis regulatory change
Separate borrower-credit benefits from competitive spread compression.
Fee-income volatility
Distinguish recurring interest income from episodic transaction fees.
Portfolio concentration
Review largest positions, affiliate exposure and industry diversification each quarter.
Final analytical takeaway
Chicago Atlantic BDC matters because it converts a difficult financing niche into a public income vehicle. Its specialist cannabis-credit expertise, secured-loan structures and adviser platform support attractive recurring investment income, while concentration, private-asset valuation, external-management incentives and regulation create unusually company-specific risks. Q1 2026 showed stronger NII and modest NAV growth, but it also showed greater leverage and unrealized depreciation. The proposed REFI merger could be transformative. The clearest test is whether LIEN can scale assets, preserve credit quality, cover distributions from recurring NII and maintain NAV per share through a changing regulatory and competitive environment.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

(LIEN) Chicago Atlantic BDC, Inc. Bundle

Get Full Bundle:
$17 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5